![Erik Strömqvist](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erik Strömqvist
Director/Board Member at
XVIVO PERFUSION AB
Net worth: 48 391 $ as of 31/07/2026
Profile
Currently, Erik Strömqvist is Chairman at MedTrace Pharma AS since 2024, Independent Director at Xvivo Perfusion AB since 2023, Director at Atley Solutions AB since 2021, and Chief Operating Officer at Swiss Nuclides AG.
Formerly, Mr. Strömqvist was Independent Director at Studsvik AB from 2021 to 2026, Director at Celcibus AB from 2020 to 2023, President at Swiss Nuclides Sweden AB, and General Manager-Cyclotrons & TRACERcenter at GE Healthcare AB from 2009 to 2020.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
XVIVO PERFUSION AB 0.01% | 31/12/2025 | 1,750 ( 0.01% ) | 48 391 $ | 31/07/2026 |
Erik Strömqvist active positions
| Companies | Position | Start |
|---|---|---|
| XVIVO PERFUSION AB | Director/Board Member | 01/01/2023 |
Swiss Nuclides AG
 Swiss Nuclides AG Hospital/Nursing ManagementHealth Services Provides cancer patients diagnostics and radiopharmaceutical therapy treatment services | Chief Operating Officer | - |
Atley Solutions AB
 Atley Solutions AB Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Director/Board Member | 01/06/2021 |
MedTrace Pharma AS
 MedTrace Pharma AS Medical SpecialtiesHealth Technology Provides medical devices for hospital departments | Chairman | 01/01/2024 |
Former positions of Erik Strömqvist
| Companies | Position | End |
|---|---|---|
| STUDSVIK AB | Director/Board Member | 21/01/2026 |
Celcibus AB
 Celcibus AB Electronic Equipment/InstrumentsElectronic Technology Manufactures hydrogen fuel cells | Director/Board Member | 01/06/2023 |
GE Healthcare AB
 GE Healthcare AB Pharmaceuticals: MajorHealth Technology Wholesales and distributes pharmaceutical products | Corporate Officer/Principal | 01/06/2020 |
Swiss Nuclides Sweden AB | President | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
56
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Studsvik AB
 Studsvik AB Miscellaneous Commercial ServicesCommercial Services Provides decommissioning and radiation protection services | Commercial Services |
GE Healthcare AB
GE Healthcare AB Pharmaceuticals: MajorHealth Technology Wholesales and distributes pharmaceutical products | Health Technology |
Xvivo Perfusion AB
 Xvivo Perfusion AB Medical SpecialtiesHealth Technology Operates as a medical technology company which develops solutions for organ, tissue, and cell preservation | Health Technology |
MedTrace Pharma AS
MedTrace Pharma AS Medical SpecialtiesHealth Technology Provides medical devices for hospital departments | Health Technology |
Atley Solutions AB
Atley Solutions AB Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Celcibus AB
Celcibus AB Electronic Equipment/InstrumentsElectronic Technology Manufactures hydrogen fuel cells | Electronic Technology |
Swiss Nuclides AG
Swiss Nuclides AG Hospital/Nursing ManagementHealth Services Provides cancer patients diagnostics and radiopharmaceutical therapy treatment services | Health Services |
Swiss Nuclides Sweden AB |
- Stock Market
- Insiders
- Erik Strömqvist
